Woodward Company Profile

✉ Email this page to a colleague

▶ Start for $1
Remove trial restrictions

WOODWARD has seventeen approved drugs.

There are two US patents protecting WOODWARD drugs.

There are fifty-one patent family members on WOODWARD drugs in seventeen countries and fourteen supplementary protection certificates in five countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Woodward	ACIPHEX	rabeprazole sodium	TABLET, DELAYED RELEASE;ORAL	020973-002	Aug 19, 1999	AB	RX	Yes	Yes		See Plans and Pricing				See Plans and Pricing
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-004	May 25, 1999		DISCN	Yes	No		See Plans and Pricing				See Plans and Pricing
Woodward	COREG CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	022012-003	Oct 20, 2006	AB	RX	Yes	Yes	7,268,156*PED	See Plans and Pricing			Y	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Woodward	COREG CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	022012-004	Oct 20, 2006	6,022,562*PED	See Plans and Pricing
Woodward	AVODART	dutasteride	CAPSULE;ORAL	021319-001	Nov 20, 2001	5,846,976	See Plans and Pricing
Woodward	COREG CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	022012-003	Oct 20, 2006	6,022,562*PED	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	0.5 mg	➤ Subscribe	2007-10-29
➤ Subscribe	Capsules	1 g	➤ Subscribe	2008-11-10
➤ Subscribe	Extended-release Capsules	10 mg and 20 mg	➤ Subscribe	2008-03-18
➤ Subscribe	Extended-release Capsules	80 mg	➤ Subscribe	2007-11-19
➤ Subscribe	Capsule	0.5 mg/0.4 mg	➤ Subscribe	2010-10-26
➤ Subscribe	Tablets	1 mg, 2 mg and 3 mg	➤ Subscribe	2008-12-15
➤ Subscribe	Extended-release Capsules	40 mg	➤ Subscribe	2007-12-21

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0658161	C300035	Netherlands	See Plans and Pricing	PRODUCT: ROSIGLITAZONE,MALEAAT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR SOLVAAT.
0658161	39/2000	Austria	See Plans and Pricing	PRODUCT NAME: ROSIGLITAZONE MALEAT; NAT. REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711; FIRST REGISTRATION: LI 55176 19990929
0306228	2001C/004	Belgium	See Plans and Pricing	PRODUCT NAME: ROSIGLITAZONE; REGISTRATION NO/DATE: EU/1/00/137/001 20000717
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.